Abstract:OBJECTIVE:Methylmalonic aciduria is the most common disorder of organic acidurias in the mainland of China. It is also the one of treatable metabolic disorders. The clinical spectrum of the patients varies from severe neonatal-onset forms with neonatal brain injury and high mortality to milder forms with adult-onset. The clinical manifestations of neonates with methylmalonic aciduria are non-specific. Early diagnosis and adequate treatment contribute a lot to improving the prognosis of the patients. In this study, the abnormal clinical and laboratory findings in neonatal period of 160 Chinese patients with early-onset methylmalonic aciduria were investigated.METHOD:From 1996 to 2011, a total of 398 patients with methylmalonic aciduria were diagnosed in our hospital; 286 (71.9%) patients had early-onset before 1 year of age. Among 286 patients, 160 (55.9%) presented symptoms in neonatal period. Their urine organic acids were analyzed by gas chromatography-mass spectrometry. Blood amino acids and acylcarnitine profiles were determined by liquid chromatography tandem mass spectrometry. Serum and urine total homocysteine were measured using a fluorescence polarization immunoassay. In some patients, gene analysis was performed. Based on the disease types and general condition, individual dietary and medical interventions were started soon after diagnosis.RESULT:Out of the 160 patients, 131 (81.9%) had combined methylmalonic aciduria and homocysteinemia. Isolated methylmalonic aciduria was found in 29 cases (18.1%). The common presentations in neonatal period were feeding difficulty, seizures, lethargy and dyspnea. Megaloblastic anemia, liver dysfunction, hyperammonemia and metabolic acidosis were the frequent findings in the routine laboratory test. The most common initial clinical diagnosis was suspected hypoxic-ischemic encephalopathy. Even in 36 cases with abnormal family history, only 3 patients were admitted with suspected inborn errors of metabolism. Five cases (3.1%) were diagnosed by postmortem metabolic examination; 7 cases (4.4%) were detected by newborn screening. In 148 cases (92.5%), the diagnosis was much delayed to the age of one month to 8 years and 5 months (mean 13 months). Methylmalonic aciduria combined with homocysteinemia (MMACHC) gene analyses were performed in 31 cases with combined methylmalonic aciduria. CblC defect was confirmed. The patients with isolated methylmalonic aciduria were treated with protein-restricted diet, cobalamin and L-carnitine. The patients of methylmalonic aciduria combined with homocysteinemia were treated with cobalamin, L-carnitine, calcium folinate, betaine and common diet. Seven patients died without treatment. Clinical improvement was observed in 153 patients. Only 2 patients detected by newborn screening had normal mental and physical development. Mild to severe psychomotor retardation was observed in 151 cases.CONCLUSION:High mortality and disability rates were observed in the patients with early-onset methylmalonic aciduria. Combined methylmalonic aciduria and homocysteinemia is the common type of methylmalonic aciduria. The clinical manifestation in neonatal period of the patients with early-onset methylmalonic aciduria is complex. Feeding difficulty, seizures, lethargy and dyspnea are the common symptoms in neonatal period of the patients. Megaloblastic anemia, liver dysfunction, hyperammonemia and metabolic acidosis were the frequent laboratory findings.

The correlation between vitamin D3 and arginine metabolism levels in newborns with amino acid metabolism disorders

[Screening for Fatty Acid Oxidation Disorders of Newborns in Zhejiang Province:Prevalence, Outcome and Follow-Up].

Comparison of Diagnostic Values of Maternal Arginine Concentration for Different Pregnancy Complications: A Systematic Review and Meta-Analysis

[Screening for Newborn Organic Aciduria in Zhejiang Province:Prevalence, Outcome and Follow-Up].

Arginine bioavailability and endothelin-1 system in the regulation of vascular function of umbilical vein endothelial cells from intrauterine growth restricted newborns.

[Genetic Analysis of Newborns with Abnormal Metabolism of 3-Hydroxyisovalerylcarnitine].

Treatment and prognosis of developmental delay in children caused by inborn errors of metabolism

Three Novel Mutations of ARG1 Identified in Chinese Patients with Argininemia Detected by Newborn Screening

Diseases Spectrum of Metabolism Disease of Amino Acid, Organic Acid and Fatty Acid Oxidation in Neonates

Neonatal Hyperammonemia and Citrullinemia Caused by Argininosuccinate Lyase Gene Mutations

Amino Acids during Pregnancy and Offspring Cardiovascular–Kidney–Metabolic Health

Meta-analysis of effectiveness and safety of early different doses of amino acid supplementation in preterm infants

Effect of Early Large Dose of Amino Acids on Growth and Metabolism of Small Preterm Infants

Retrospective analysis of the correlation between serum vitamin D levels and blood amino acids levels in children with autism: Exploration of possible mechanisms of the effect of vitamin D on autism

A case of neonatal death due to argininosuccinic aciduria

Vitamin D levels in cord blood of newborn and in blood of infant:a correlation study

[Abnormal Findings During Newborn Period of 160 Patients with Early-Onset Methylmalonic Aciduria].

A Probable Way Vitamin D Affects Autism Spectrum Disorder: The Nitric Oxide Signaling Pathway

Amino acid metabolism in health and disease

Vitamin D Metabolic Pathway Genes Polymorphisms and Vitamin D Levels in Association with Neonatal Hyperbilirubinemia in China: a Single-Center Retrospective Cohort Study.

Genetic Background and Clinical Characteristics of Infantile Hyperammonemia.